Main » Press Releases & News » Vibrant raises $7.5M for innovative drug-free constipation treatment

Vibrant raises $7.5M for innovative drug-free constipation treatment

Published: March 26, 2021

Vibrant, a medical technology company that’s developed a disposable vibrating pill to treat chronic constipation, today announced its Series E for $7.5 million. The company is based in Tel Aviv and is lead by Lior Ben-Tsur, a startup veteran. Since its founding in 2007, the company has raised a total of $25 million. This round is being led by Unorthodox Ventures, with participation by Sequoia.

Posted on:

https://techcrunch.com/2021/03/26/vibrant-raises-7-5m-for-a-drug-free-mechanical-pill-to-treat-constipation/

Related Press Releases & News

IT Awards 2022

Exciting news! Vibrant Gastro has won the @Israeli IT Award People & Computers 2022 for our Salesforce project in the digital transformation and innovation category.

Drug-free relief from chronic constipation may come from a new vibrating pill

People who struggle with chronic constipation have a new drug-free option to help get things moving again. It’s a first-of-its-kind capsule about is the size

FDA grants marketing authorization for Vibrant®, a new first-in-class, drug-free treatment for adults with chronic idiopathic constipation

Vibrant Gastro Inc. announced today that the Food and Drug Administration (FDA) granted marketing authorization for the Vibrant®, an orally administered drug-free capsule, for the

Let's be friends -

1. Gut inference: A computational modelling approach: July 22, 2021, Appears in: Biological Psychology
2. Long range synchronization within the enteric nervous system underlies propulsion along the large intestine in mice: August 10, 2021, Appears in: Communications Biology, Nature.com
3. SLACK Incorporated, “Current Insights About Constipation: October 2018
4. Gastroenterology Published: February 20, 2023 https://doi.org/10.1053/j.gastro.2023.02.013, Rao SSC et al

This site is published by Vibrant Gastro, Inc. which is solely responsible for its content.
This site is intended for visitors from the United States. The trademarks used herein are trademarks of their respective owners.